Hexamethylene diisocyanate (HDI) vapor reactivity with glutathione and subsequent transfer to human albumin
Public Domain
-
2013/03/01
-
Details
-
Personal Author:
-
Description:Introduction: Airway fluid glutathione (GSH) reactivity with inhaled vapors of diisocyanate, a common occupational allergen, is postulated to be a key step in exposure-induced asthma pathogenesis. Methods: A mixed (vapor/liquid) phase exposure system was used to model the in vivo reactivity of inhaled HDI vapor with GSH in the airway fluid. HDI-GSH reaction products, and their capacity to transfer HDI to human albumin, were characterized through mass spectrometry and serologic assays, using HDIspecific polyclonal rabbit serum. Results: HDI vapor exposure of 10 mM GSH solutions resulted in primarily S-linked, bis(GSH)-HDI reaction products. In contrast, lower GSH concentrations (100 lM) resulted in mainly mono(GSH)-HDI conjugates, with varying degrees of HDI hydrolysis, dimerization and/or intra-molecular cyclization, depending upon the presence/absence of H2PO4-/HPO42- and Na+/CI- ions. The ion composition and GSH concentration of the fluid phase, during HDI vapor exposure, strongly influenced the transfer of HDI from GSH to albumin, as did the pH and duration of the carbamoylating reaction. When carbamoylation was performed overnight at pH 7, 25 of albumin's lysines were identified as potential sites of conjugation with partially hydrolyzed HDI. When carbamoylation was performed at pH 9, more rapid (within 3 h) and extensive modification was observed, including additional lysine sites, intra-molecular crosslinkage with HDI, and novel HDI-GSH conjugation. Conclusions: The data define potential mechanisms by which the levels of GSH, H2PO4 -/HPO42-, and/or other ions (e.g. H+/OH-, Na+, Cl-) affect the reactivity of HDI vapor with self-molecules in solution (e.g. airway fluid), and thus, might influence the clinical response to HDI respiratory tract exposure. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0887-2333
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:27
-
Issue:2
-
NIOSHTIC Number:nn:20042036
-
Citation:Toxicol In Vitro 2013 Mar; 27(2):662-671
-
Contact Point Address:Adam V. Wisnewski, Yale School of Medicine, 300 Cedar Street, TACS4157, P.O. Box 208057, New Haven, CT 06520 8057
-
Email:adam.wisnewski@yale.edu
-
CAS Registry Number:
-
Federal Fiscal Year:2013
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:Toxicology in Vitro
-
Collection(s):
-
Main Document Checksum:urn:sha-512:92b7cc3dd2b632d676088dd04dc8a45699191c7bcb7f36a410e140d8a03d224cf9140576bf848340d9799b7ba84fc0e9501136239fd130c4dccdc76d322ed733
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like